WALTHAM, Mass.--(BUSINESS WIRE)--Pyramid Biosciences, Inc., a Boston-based, clinical-stage biotechnology company focused on developing new and highly differentiated precision therapies for cancer and ...

WALTHAM, Mass.--(BUSINESS WIRE)--Pyramid Biosciences, Inc., a Boston-based, clinical-stage, biotechnology company focused on developing new and highly differentiated precision therapies for cancer, ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Hamilton's Pyramid Hill ...

Bryan Knicely has been appointed as executive director of Pyramid Hill Sculpture Park & Museum. “Bryan has impressive industry knowledge, and his collaborative leadership style will harness the talent ...

Doug Sickler, former vice president of business development at Technica, has joined Pyramid Systems as senior vice president and chief growth officer. He will be responsible for overseeing BD and ...

LONDON, NEW YORK and TEL AVIV, Israel, Jan. 4, 2023 — Pyramid Analytics (Pyramid), a pioneering provider of an augmented analytics platform for decision intelligence, has been identified as a ...

Stay ahead with unbiased news, expert commentary, and in-depth features on global topics. As a trusted provider of data and insights, Just Drinks collaborates closely with industry leaders and ...

Pyramid Biosciences’ pipeline is focused on clinical-stage precision medicines, including its lead program PBI-200, a next-generation, highly CNS penetrant tropomyosin receptor kinase (TRK) inhibitor ...